Annexon (NASDAQ:ANNX – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Tuesday, March 25th. Analysts expect Annexon to post earnings of ($0.28) per share for the quarter.
Annexon (NASDAQ:ANNX – Get Free Report) last released its earnings results on Monday, March 3rd. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.05). On average, analysts expect Annexon to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Annexon Price Performance
ANNX opened at $2.75 on Tuesday. Annexon has a 12 month low of $2.30 and a 12 month high of $8.40. The stock has a market capitalization of $301.70 million, a price-to-earnings ratio of -2.62 and a beta of 1.14. The business has a fifty day moving average price of $3.44 and a 200 day moving average price of $5.19.
Wall Street Analyst Weigh In
Read Our Latest Report on ANNX
Annexon Company Profile
Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.
Featured Articles
- Five stocks we like better than Annexon
- 3 Small Caps With Big Return Potential
- Can TikTok Stock Picks Really Make You Rich?
- Best Aerospace Stocks Investing
- The “Quality” Rotation: Back to Basics Investing
- What Are Growth Stocks and Investing in Them
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Annexon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Annexon and related companies with MarketBeat.com's FREE daily email newsletter.